Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 160040-04-0 hpv16-e711-20epitope in China, also supports custom service. Welcome to wholesale bulk high quality cas 160040-04-0 hpv16-e711-20epitope from our factory. Contact us for more details.
| Description | High-risk HPV16 E7 residues 11–20, a tumor-cell-specific CD8+ T epitope; used for HPV-associated cervical-cancer therapeutic vaccines and tumor immunology. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| HPV16-E7 11-20 epitope (YMLDLQPETT, HLA-A*0201) | YMLDLQPETT; CAS 160040-04-0; HPV16 E7 oncoprotein 11-20 epitope; HPV16-E7 11-20 CTL epitope | Tumor immunology, HPV-associated cancer, Therapeutic vaccine, Cervical cancer, Adoptive T-cell therapy, HLA-A*0201 | H-Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr-OH. A canonical HLA-A*0201-restricted decamer from HPV16 E7 oncoprotein residues 11-20; free N-terminal amino / free C-terminal carboxyl; contains 1 Met + 1 Tyr; moderate hydrophobicity. | C53H83N11O19S | 1209.56 | 1210.36 | TFA salt / free peptide (per supplier COA) | 10 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-HPVE711-01 | White to off-white powder | Store at -20°C, dry, sealed, light-protected; Met/Tyr-containing - keep light-protected, deaerated, avoid oxidants. | Short-term storage at 2-8°C, dry and light-protected; avoid repeated freeze-thaw. | Prepare fresh; moderately hydrophobic, dissolves directly in aqueous buffer; use a small fraction of DMSO if needed; store stock in aliquots at -20°C, light-protected. | powder stable for 1-2 years at -20°C, sealed and light-protected. |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-HPVE711-01 | HLA-A*0201-restricted CTL epitope from HPV16 E7 (11-20), a 10-mer target for cervical-cancer immunotherapy research. | HLA-A*0201-restricted CTL epitope from HPV16 E7 oncoprotein residues 11-20; a canonical target for therapeutic vaccine and adoptive T-cell studies in HPV16-associated cervical cancer. | Tumor immunology, HPV-associated cancer, Therapeutic vaccine, Cervical cancer, Adoptive T-cell therapy | Presented on HLA-A*0201 to CD8+ T cells; recognizes HPV16 E7-expressing cervical carcinoma cells. |
Hot Tags: cas 160040-04-0 hpv16-e711-20epitope, China cas 160040-04-0 hpv16-e711-20epitope manufacturers, suppliers, factory, 199727-68-9, 2293841-58-2, BCMA72-80, CAS 124454 83 7, CAS 199727 68 9, Nucleoprotein 118 126
